Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy.

MLA

Chang, Hao ‐.Nan, et al. “Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy.” Angewandte Chemie, vol. 127, no. 40, Sept. 2015, pp. 11926–30. EBSCOhost, https://doi.org/10.1002/ange.201506225.

APA

Chang, H. ‐ N., Liu, B. ‐ Y., Qi, Y. ‐ K., Zhou, Y., Chen, Y. ‐ P., Pan, K. ‐ M., Li, W. ‐ W., Zhou, X. ‐ M., Ma, W. ‐ W., Fu, C. ‐ Y., Qi, Y. ‐ M., Liu, L., & Gao, Y. ‐ F. (2015). Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy. Angewandte Chemie, 127(40), 11926–11930. https://doi.org/10.1002/ange.201506225

Chicago

Chang, Hao ‐ Nan, Bei ‐ Yuan Liu, Yun ‐ Kun Qi, Yang Zhou, Yan ‐ Ping Chen, Kai ‐ Mai Pan, Wen ‐ Wen Li, et al. 2015. “Blocking of the PD-1/PD-L1 Interaction by a D-Peptide Antagonist for Cancer Immunotherapy.” Angewandte Chemie 127 (40): 11926–30. doi:10.1002/ange.201506225.